Aurobindo Pharma jumps after its arms ink pact with affiliate of New Mountain Capital LLC, NY, Jarrow Formulas Inc

01 Dec 2020 Evaluate

Aurobindo Pharma is currently trading at Rs. 891.15, up by 23.10 points or 2.66% from its previous closing of Rs. 868.05 on the BSE.

The scrip opened at Rs. 870.00 and has touched a high and low of Rs. 896.60 and Rs. 870.00 respectively. So far 73461 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 967.60 on 10-Aug-2020 and a 52 week low of Rs. 281.15 on 23-Mar-2020.

Last one week high and low of the scrip stood at Rs. 896.60 and Rs. 834.95 respectively. The current market cap of the company is Rs. 52116.31 crore.

The promoters holding in the company stood at 52.01%, while Institutions and Non-Institutions held 36.68% and 11.31% respectively.

Aurobindo Pharma’s wholly owned subsidiary -- Aurobindo Pharma USA, Inc. and Natrol LLC, USA, a wholly owned step -down subsidiary of the Company, have entered into a definitive agreement with an affiliate of New Mountain Capital LLC, NY and Jarrow Formulas Inc., to dispose of Natrol LLC, USA, including its business assets as a going concern with related assets, liabilities, products, brands and employees.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1089.45 19.45 (1.82%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.